The stem cell-intrinsic model of selfrenewal via asymmetric cell division (ACD) posits that fate determinants be partitioned unequally between daughter cells to either activate or suppress the stemness state. ACD is a purported mechanism by which hematopoietic stem cells (HSCs) self-renew, but definitive evidence for this cellular process remains open to conjecture. To address this issue, we chose 73 candidate genes that function within the cell polarity network to identify potential determinants that may concomitantly alter HSC fate while also exhibiting asymmetric segregation at cell division. Initial gene-expression profiles of polarity candidates showed high and differential expression in both HSCs and leukemia stem cells. Altered HSC fate was assessed by our established in vitro to in vivo screen on a subcohort of candidate polarity genes, which revealed 6 novel positive regulators of HSC function: Ap2a2, Gpsm2, Tmod1, Kif3a, Racgap1, 
Introduction
Self-renewal is inextricably linked to stem cell division, and despite the premise that these processes in mammalian systems likely involve asymmetric cell division (ACD), the molecular details remain enigmatic. Our approach to addressing self-renewal via ACD in the hematopoietic stem cell (HSC) is based on increasing evidence that the mechanistic insights pertaining to polarity molecular networks, which are integral to ACD and cell fate in the invertebrate models of Drosophila melanogaster and Caenorhabditis elegans, are functionally conserved throughout evolution. [1] [2] [3] Studies from invertebrate models support both extrinsic (niche) and stem cell-intrinsic mechanisms of ACD. In relation to the cell intrinsic machinery, polarity is initiated by asymmetrically localizing protein complexes to the cell membrane. Subcomponents of these complexes act as cell fate determinants that are maintained asymmetrically during mitosis and subsequently segregated differentially into daughter cells. During this process, at the simplest level and without factoring in other potential organelle 4, 5 or cell cycle component interactions, 6, 7 these membrane complexes interact with centrosomes and the cytoskeletal network to, respectively, anchor and enable correct mitotic spindle orientation for an ACD. [8] [9] [10] The distinct advantages of these invertebrate models include the ability to follow the end fate of daughter cells during successive rounds of ACD together with real-time video tracking to observe the clear segregation of established cell-fate determinants during and after the ACD process. In contrast, within the hematopoietic system, these advantages are attenuated by the absence of definitive HSC markers or cell fate determinants that could allow for investigations of successive divisions of long-term repopulating HSCs (LT-HSCs). The added factor of HSC motility outside of its niche further hinders prospective daughter cell fate analysis.
Despite these limitations, important aspects of HSC selfrenewal with indirect implications for ACD as a mechanism have been reported. For example, for many decades, single-cell manipulations with more enriched HSC populations over time have documented different in vitro 11, 12 and in vivo [13] [14] [15] cell fates. Further, asymmetric segregation of proteins within the hematopoietic system has also been reported previously, [16] [17] [18] but did not confirm alterations in cell fate because in vivo daughter cell assays were not tenable in these studies. Other studies have used live-cell videomicroscopy of single cells derived from a population enriched for HSCs together with clonal fate of progeny as measured by in vivo repopulation assays to provide morphological clues as to the identity of LT-HSCs; however, this was done without confirming ACD per se in this setting. 19 Far from being a critique, these examples reflect the difficulty of directly connecting ACD to daughter cell fate within the heterogeneity of the HSC system. The present study was undertaken to provide further evidence that the process of ACD is functional in HSC fate and to serve as a foundation for ongoing future studies that may allow ACD, HSC fate, and self-renewal to be directly and mechanistically linked.
Methods
Procedures for retroviral vectors, animal husbandry, HSC isolation, quantitative RT-PCR expression studies, BM cell culture, retroviral infection and transplantation, flow cytometric assessment of donor-derived hematopoiesis, Southern blot analysis of genomic DNA, competitive repopulating units (CRU) assay of HSC-enriched cells, and cell proliferation and cell death analyses were as detailed in Deneault et al. 20 All animal procedures were performed with approval from the Animal Ethic Committees of University of Montreal and Peter MacCallum Cancer Institute. For resource information, please see http://www.bioinfo.iric.ca/self-renewal/.
Confocal microscopy
Mouse adult BM and embryonic day 14.5 (E14.5) fetal liver (FL) cells were isolated independently and lineage depleted by staining with allophycocyanin (APC)-conjugated primary Abs to Gr1, B220 and Ter119 (all from BioLegend). Respective BM and FL cells were stained with anti-APC magnetic microbeads according to manufacturer guidelines (Miltenyi Biotec), and lineage positive (Lin ϩ ) cells were depleted using the AUTO-MACS magnetic cell separator system (BD Biosciences). For the adult BM cells, lineage negative (Lin Ϫ ) cells were stained with PE-CD150, APC-CD48, PE-Cy5-Sca, and PE-Cy7-Kit conjugated Abs, and the enriched CD150 ϩ 48 Ϫ Lin Ϫ Sca ϩ Kit ϩ (LSK) subpopulation of cells collected by flow cytometry using the FACSAria II (BD Biosciences). For the FL cells, Lin Ϫ cells were stained with PE-CD150, APC-CD48, PE-Cy5-Sca, and FITCMac-conjugated Abs and the enriched CD150 ϩ 48 Ϫ Sca ϩ Mac1 ϩ Lin Ϫ subpopulation of cells was collected. These respective subpopulations of cells were resuspended in DMEM with 15% FBS. Respective BM-and FL-enriched subpopulations up to 50 000 cells per slide were seeded onto poly-L-lysine-coated coverslips and incubated at 37°C for 60 minutes. Cells were then fixed with 4% paraformaldehyde for 15 minutes at 4°C and permeabilized with PBS, 1% BSA, 0.1% Tween and stained with primary Abs to Ap2a2 (AP6, ab2730; Abcam) and/or Numb (ab4147; Abcam) and revealed by Alexa Fluor 488-and/or Alexa Fluor 594-labeled secondary Abs (Molecular Probes). Fluorescent images were obtained with a confocal microscope (LSM510; Zeiss).
Videomicroscopy
Freshly sorted PE-CD150 ϩ /APC-CD48 Ϫ /PE-Cy5-Sca ϩ /PE-Cy7-cKit ϩ / Lin Ϫ BM cells from histone H2B-GFP mice were transduced with retroviral producers infected with MSCV-cherry-Ap2a2 and/or pCXIBSR-venusNumb vectors for 3 days. Cells were then sorted based on forward and side scatter to differentiate between hematopoietic and feeder cells. Isolated hematopoietic cells in BM medium 20 were seeded into 8-mm sterile cloning discs (F378470100; Bel-Art Scienceware) placed on glass-bottom MakTek dishes (number 1.5; MatTek) of a confluent and irradiated (1500 cGy of 137 Cs ␥ radiation) layer of either NIH 3T3 or OP9 cells. Video imaging comprised 3 colors (green fluorescence, red fluorescence, and transmitted light) and 4 z-sections 2.5 m apart every 15 minutes for 24 hours with an Olympus 60ϫ/1.42 numerical aperture oil-immersion lens and a Photometric CoolSnap HQ2 camera on a DeltaVision video microscope fitted with a 37°C environmental chamber (Applied Precision). Video analyses were performed with softWoRxExplorer Version 2.0 (Applied Precision) and Imaris software (Bitplane Scientific Software).
Statistical analysis
Statistical significance was determined with the 2-tailed Student t test.
Results

Candidate polarity screen for HSC expansion
Using existing expression databases 21 and literature analyses, we compiled a candidate gene list of polarity cell-fate determinants for initial gene-expression profiling. Given the heterogeneity of the HSC compartment, we used 2 established enriched HSC subpopulations, the CD150 ϩ 48 Ϫ 41 Ϫ Lin Ϫ and the CD49b Ϫ rhodamine low LSK cells, for assessment ( Figure 1A -C and supplemental Table 1 , available on the Blood Web site; see the Supplemental Materials link at the top of the online article). These gene-expression profiles show that a broad range of polarity candidates are highly and differentially expressed in both HSCs and leukemia cells ( Figure  1A -C). To assess whether polarity genes would be altered by an established HSC expansion factor, 22 we profiled gene-expression levels of a subset of candidate genes after HSCs were transduced with HoxB4 and with MSCV vector ( Figure 1D ). These data show that HoxB4 does not affect this subset of polarity candidate genes at the mRNA level.
Based on our gene-expression profiles (Figure 1 ), 43 (ϳ 60%) of the candidates were chosen to assess whether any of these genes could alter the fate of LT-HSCs using an established gain-offunction in vitro to in vivo assay (for full details, see Deneault et al 20 ; Figure 2A -B and http://www.bioinfo.iric.ca/self-renewal/). The theoretical essence of this screen is based on the relative inability of HSCs to preserve functional identity (ie, self-renewal) during a period of in vitro culture when apoptosis or differentiation are the predominant HSC fate, and as measured by the relative absence of in vivo repopulation of sublethally irradiated recipients after transplantation. In contrast, transduction by a candidate fate-transforming gene to either maintain or expand the HSC population after in vitro culture would result in a predominant donor-derived in vivo transplantation output. Briefly, 1500 enriched CD150 ϩ 48 Ϫ Lin Ϫ HSCs (equivalent to ϳ 62 CRUs per well or 8 CRUs per transplanted mouse 20 ) from CD45.1 mice were transduced with high titer retroviruses produced from transfections with the candidate genes and cultured in vitro for 7 days before transplantation into 3 recipient CD45.2 mice. Every 4 weeks up to 16 weeks, donor-derived WBC reconstitution was assessed. The 2 negative controls were HSCs transduced with vectors pKOF and MSCV, and the 2 positive controls were transduced with the NUP98-HOXA10 fusion (NA10HD) 23 and HoxB4, 22, 24 with the positive cutoff set at the latter's mean reconstitution of 30% at 16 weeks. This primary screen revealed 6 (14%) positive candidates that significantly increased hematopoietic reconstitution: Ap2a2, Gpsm2, Tmod1, Kif3a, Racgap1, and Ccnb1. See Figure 2B and supplemental Table 2 for full results without (day 0) and with (day 7) in vitro culture. We initially focused on the candidate Ap2a2 because it was the most potent HSC expansion gene within the screening experiments ( Figure 2B ). The other positive candidates will be analyzed subsequently.
Validation and self-renewal of Ap2a2-transduced HSCs in vitro
To validate Ap2a2 as a genuine candidate, we performed 3 further independent in vitro to in vivo assays with the mean reconstitution levels from each assay supporting the initial screen results ( Figure 2C and Ap2a2 gene results at http://www.bioinfo.iric.ca/selfrenewal/). We also confirmed the expression of the Ap2a2 protein from NIH 3T3 (ie, GPϩE-86) producer cells used during HSC transduction ( Figure 2D ). To ensure that aberrant retroviral insertion was not aiding the reconstitution advantage of Ap2a2-transduced HSCs, we performed clonal analysis of cells obtained from BM and thymus from 2 reconstituted mice ( Figure 2E ). This showed the presence of many clones in different mice, together with multipotentiality of transduced cells, because the same clones were present in both myeloid (BM) and lymphoid (thymus) predominated tissues of the same mouse. Further evidence of the multipotency was provided by flow cytometric analysis from a representative recipient mouse transplanted with Ap2a2-transduced HSCs sorted on donor CD45.1 cells with B-cell (B220), monocytemacrophage (CD11b), and mature T-cell (CD4 and CD8) reconstitution ( Figure 2F ).
CRU assays were performed to validate and determine whether Ap2a2-transduced HSCs expand and/or are maintained ex vivo 24, 25 ( Figure 3A) . Initially, (based on day 0 CRU assays) 200 CD150 ϩ 48 Ϫ Lin Ϫ HSCs from CD45.1 mice were transduced with Ap2a2 pKOF vector (for the negative control) and HoxB4 and NA10HD (for the positive controls), cultured for 7 days in vitro, and transplanted in limiting cell numbers into sublethally irradiated CD45.2 recipients. Analyses of donor WBC reconstitution at 12 weeks were used to determine CRU frequencies. The respective frequencies were: pKOF (1 in 457 107), Ap2a2 (1 in 136 135), HoxB4 (1 in 8165), and NA10HD (1 in 1036) cells ( Figure 3A) . Interestingly, when these calculated CRU frequencies were analyzed in relation to the input 200 CRU cells at day 0 and the absolute numbers of cells at the end of the in vitro culture period, the following differences were found: a 29-fold reduction in CRU cells after transduction with pKOF, an 11-fold reduction in Ap2a2, a 2-fold increase in HoxB4, and a 19-fold increase in NA10HD. These results suggest that the enhanced HSC activity invoked by Ap2a2 transduction may be attributable to a relative reduced loss and/or maintenance of HSC numbers in vitro coupled with a proliferative effect in vivo after transplantation.
To look further for self-renewal of expansion in vitro, we looked for clonal expansion of Ap2a2-transduced HSCs by analyses of proviral integration patterns from 11 primary recipients ( Figure  3B ). Based on the absence of the same clones in any of these 11 mice from 4 independent cell culture populations ( Figure 3B ), Figure 1 . Gene-expression profiles of HSC polarity fate determinants. Candidate genes were classified according to Gene Ontology (GO) groups (see below) based initially on biologic process (Groups I-XI). In the absence of a biologic process, they were then based on molecular function (Group XII) and cellular component (Group XIII). The expression of these candidate genes was performed on purified HSC populations compared with more differentiated progenitors. Each dataset is represented by the mean average ␦Ct from 2 experiments in which for each respective reference range, the lowest numbers (green bars) correspond to the highest transcript copy numbers. Shown are gene expressions from (A) HSCs sorted on CD150 ϩ 48 Ϫ 41 Ϫ Lin Ϫ (with a stem cell frequency of 1 in 10 based on CRUs; data not shown) and progenitors CD150 ϩ 48 ϩ 41 Ϫ Lin Ϫ (B) HSCs sorted on CD49b Ϫ rhodamine low LSK (with a stem cell frequency of 1 in 8 based on CRUs, data not shown) and progenitors CD49b Ϫ rhodamine high LSKs, and (C) 2 independent murine leukemias, FLA2 and FLB1, derived from HoxA9 ϩ Meis1 transduced FL cells, that differ in leukemia stem cell frequency of, respectively, 1 in 1.4 and 1 in 347 (based on previous CRU, data not shown). (D) A subset of these candidate genes were profiled after CD150 ϩ 48 Ϫ 41 Ϫ Lin Ϫ HSCs were transduced with the established expansion factor HoxB4 and compared with MSCV vector alone transduced HSCs. GO Groups: I_GO_7049 cell cycle; II_51301 cell division; III_30154 cell differentiation; IV_45165 cell-fate commitment; V_7163 establishment or maintenance of cell polarity; VI_16192 vesicle mediated transport; VII_16459 myosin complex; _7017 microtubulebased process; VIII_7154 cell communication; IX_50678, _7242, _7169, _6468 receptor signaling pathways; X_48729 tissue morphogenesis; and, _43066 negative regulation of apoptosis; XI_33036, _51234 macromolecule and establishment of localization; XII_5515, _8092 protein and cytoskeleton binding; _3774 motor activity; _8266, _3723 RNA binding; and XIII_5886,16 020 membrane; _45177 apical part of cell. From studies shown in panels A through C, a scoring criteria (data not shown) based on the absolute average ␦Ct and the relative expression in the stem versus progenitor cell populations was used to quantify the candidates chosen for the in vitro to in vivo overexpression screen (see also supplemental Table 1 ).
we surmised that there was no clear evidence of predominant in vitro symmetric self-renewal with Ap2a2 during our 7 days of culture. In contrast, similar clonal analyses from the majority of transcriptional positive regulators of HSCs from our previous screen 20 showed symmetric self-renewal divisions in vitro.
In the context of seemingly limited numbers of Ap2a2-transduced HSCs providing enhanced HSC function, we quantified For personal use only. on June 10, 2017. by guest www.bloodjournal.org From CD45.2 subpopulations of recipient mice 20 weeks after transplantation ( Figure 3C ). In the Ap2a2-transduced mice, the percentage of LT-HSCs was less in the donor CD45.1 population compared with the CD45.2 recipient-competitor cells ( Figure 3C ). In contrast, measurement of the proliferative output per Ap2a2-transduced LT-HSCs using the mean activity of stem cell (MAS), as detailed in our previous functional screen for HSC activity, 20 revealed a 13-fold higher MAS for Ap2a2-transduced LT-HSCs when normalized to freshly sorted HSCs ( Figure 3D ). This relative MAS activity is not only higher, but is also statistically more significant, than both Hoxb4-transduced and the most potent gene from our initial screen, Trim27-transduced cells 20 ( Figure 3D-E) . This suggests that Ap2a2-transduced HSCs possess the ability for superior proliferative output per HSC.
These studies of in vitro cultured Ap2a2-transduced HSCs revealed increased HSC activity in vivo ( Figure 3D-E) , but the absence of obvious in vitro HSC expansion based on CRU assay ( Figure 3A ) and clonal analyses in primary recipients ( Figure 3B ) or quantitative increases in LT-HSCs ( Figure 3C ) suggests that Ap2a2 induces maintenance of HSCs in vitro that is translated to an in vivo proliferative advantage by either a preference for asymmetric self-renewal divisions and/or a qualitative change in LT-HSCs.
Self-renewal of Ap2a2-transduced HSCs in vivo
Secondary transplantation assays were performed to assess whether Ap2a2-transduced LT-HSCs retained self-renewal capacity in vivo. Eleven primary Ap2a2-transduced mice ( Figure 3B Figure 2B and C. Because these Ap2a2-transduced assays were performed in conjunction with our previous overexpression screen, 20 in which the control CRU was known for freshly purified CD150 ϩ 48 Ϫ Lin Ϫ HSCs, the published data for fresh cells, days 0 and 7 grafts, and positive grafts for Hoxb4-and Trim27-transduced cells are used as valid negative controls and positive comparators, respectively. The MAS for Ap2a2 (*) is statistically significantly higher (see value in panel E), compared with day 0 and 7 controls. (E) P value for Ap2a2-transduced HSCs derived from MAS data in panel D compared with published control vectors (day 0 or 7) and the most potent HSC activators from our initial screen. 20 another experiment with high Ap2a2-transduced HSC donor reconstitution were killed at Ն 16 weeks and used as primary donors. Approximately 5 ϫ 10 6 cells (without congenic helper cells) were transplanted into 4 secondary recipients per primary mouse ( Figure  4A -B) and analyzed 23 weeks after transplantation. Positive donor reconstitution in the majority of secondary recipients confirmed that Ap2a2-transduced HSCs exhibited prolonged in vivo activity within the primary mouse ( Figure 4A ). Secondary recipient BM and thymic tissue gated on donor CD45.1 expressed markers for B-cell, myeloid cell, and T-cell lineages, suggesting that donor cells retained lymphomyeloid differentiation capacity (data not shown).
To assess for in vivo clonal composition, one primary donor from Figure 3B ) and their respective (sr) mice (as numbered and indicated by respective color codes). (C) CRU assay in secondary recipients. From 3 further independent in vitro to in vivo assays with vector-transduced and Ap2a2-transduced CD45.2 donor CD150 ϩ 48 Ϫ Lin Ϫ HSCs transplanted into CD45.1 recipients: 1 representative primary CD45.1 recipient mouse from each assay was taken at 20 weeks after transplantation (supplemental Figure 1A) . Figure 3B , together with respective multiple secondary recipients, were analyzed for proviral integrations ( Figure 4A-B) . This showed at least 2 independent clones from each primary donor in multiple respective secondary recipients ( Figure 4B ), which is consistent with clonal in vivo symmetric cell divisions.
Because clonal symmetrical HSC divisions may be expected to occur in the transplantation setting, to quantify the in vivo self-renewal of Ap2a2-transduced HSCs, we performed CRU assays in another batch of secondary recipients (Figure 4C Figure 4D ).
To correlate and quantify HSC numbers after in vivo selfrenewal, 10 of these secondary recipient mice (2 vector transduced and 8 Ap2a2 transduced) were killed at 20 weeks for analyses of donor CD45.2-derived versus competitor CD45.1-derived BM LSK subpopulations ( Figure 4E ). When normalized to an equivalent 200 000 CD45.1 competitor cell dose, the percentage of LSK cells in the Ap2a2-transduced CD45.2-derived population showed a modest but statistically significant 2-fold greater increase in the Ap2a2-transduced CD45.2 donor-derived LSK population ( Figure 4E ).
These secondary recipients reconstitution results show that Ap2a2-transduced HSCs have a modest quantitative in vivo self-renewal expansion yet maintain potent HSC reconstitution activity ( Figure 4C-E) . These results are similar to the in vitro to in vivo transplantation assay results in primary recipients ( Figure  3A-E) , in which the increased Ap2a2-transduced HSC reconstitution is also seen without a significant corresponding quantitative increase in HSCs. This suggests that the Ap2a2-induced enhanced HSC activity occurs mostly in vivo both in primary and secondary recipients.
Effect of Ap2a2 shRNA in HSCs
We further investigated the role of Ap2a2 in HSC activity by studying the impact of shRNAs that reduce Ap2a2 mRNA levels by 50%-90% within the context of our in vitro to in vivo reconstitution assay (supplemental Figure 2A-B) . Results from these experiments suggest that Ap2a2 is dispensable for hematopoiesis. Homing efficiency as measured by the percentage of donor CD45.2-transduced cells in the BM of recipients 24 hours after transplantation and annexin V apoptosis assays of respective transduced HSCs cultured for 7 days in vitro revealed no significant differences between 3-, 4-, and 5-shAp2a2-transduced HSCs compared with shRNA luciferase-transduced CD150 ϩ 48 Ϫ Lin Ϫ HSCs (data not shown).
These Ap2a2 knockdown assay results, together with the findings from our previous screen of non-cell-autonomous activity for other positive regulators of HSC expansion during in vitro culture, 20 led us to assess whether such activity was also aiding the in vivo effect of Ap2a2-transduced cells. Using non-viralproducing NIH 3T3 cells for transfection with Ap2a2, followed by subsequent HSC coculture and transplantation (for details, see Deneault et al 20 ) , we found no evidence for non-cell-autonomous contribution (data not shown). We conclude that overexpression of Ap2a2-transduced HSCs results in enhanced HSC activity after in vivo transplantation, whereas knockdown of Ap2a2 in HSCs suggests that Ap2a2 has a redundant role within the limits of the in vitro culture and transplantation assay.
Evaluation of Ap2a2-transduced HSCs
We next assessed whether we could detect qualitative differences in Ap2a2-transduced HSCs by looking at the effects of Ap2a2 overexpression on proliferation, survival, or differentiation of CD150 ϩ 48 Ϫ Lin Ϫ cells. The absolute cell count after in vitro culture of CD150 ϩ 48 Ϫ Lin Ϫ cells transduced with pKOF, Ap2a2, HoxB4, and NA10HD (60%-69% gene transfer) showed that the number of Ap2a2-transduced cells was not enhanced (Figure 5A ). In vitro proliferation analyses with methylcellulose colony forming assays showed that Ap2a2-transduced HSC progenitor cells were capable of producing the full spectrum of differentiated colonies ( Figure  5B ) with no differences in colony size (data not shown). Differentiation arrest has been found to contribute to the prominent HSC expansion mediated by HoxB4 and NA10HD. 25 However, Ap2a2-transduced HSCs show a limited differentiation arrest compared with NA10HD-transduced HSCs ( Figure 5C -D blue bars).
Other key cellular pathways assessed via in vitro analyses of LSK cells transduced with and without Ap2a2 for 5 days were: cell cycle by Hoechst/phospho-histone H3 and bromodeoxyuridine pulse and chase for 24 hours, cell death by annexin V/propidium iodide, senescence by ␤-galactosidase, and measurement of cell divisions using cell track violet for up to 10 days in culture. None of these assays showed differences between Ap2a2-transduced and vector-transduced cells (data not shown). Ap2a2 modestly inhibits primitive hematopoietic cell differentiation in vitro without altering apoptosis and the other key cellular processes involved in self-renewal.
Another important property of the stem cell is the ability to remain quiescent until actively required. This concept has been highlighted within the hematopoietic system by the identification of a small population of multipotent, dormant LT-HSCs. 26, 27 To assess this in vivo, we assessed the cell-cycle status from 10 secondary recipients killed at 20 weeks. The LSK subpopulations from the Ap2a2-transduced CD45.2 donor-derived and competitor CD45.1-derived subpopulations were stained with DAPI-Ki67 to assess in particular the percentage of cells in G 0 . There was no difference in G 0 or any other cell-cycle parameters between the 2 cell subpopulations (data not shown).
Because the dormant LT-HSC population is both small and heterogenous, detection of a difference at the bulk population level would be difficult. To circumvent this and to further investigate the Ap2a2-quiescence link, we isolated from independent sorts batches of 30-50 cells of the LT-HSC and multipotent intermediate-term HSC (IT-HSC) 28 populations while in quiescence and in cell cycle for Ap2a2 expression. This IT-HSC population, isolated in the CD49b hi rhodamine low LSK fraction and separable from the classic short-term repopulating HSCs, generates multilineage clones that expand through to 8 weeks. Although the clones subsequently regress, lymphoid components remain detectable beyond 6 months. In contrast, the established LT-HSCs (CD49b Ϫ rhodamine low LSK) sustain multilineage reconstitution beyond 6 months and for the lifetime of the animal. Gene expression was measured on Affymetrix microarrays (for details, see Benveniste et al 28 ). These results (supplemental Figure 2C) suggest that Ap2a2, and to a lesser degree Numb, are preferentially expressed in the quiescent versus the cycling state of both the LT-HSCs and IT-HSCs. To quantify these microarray results, we performed quantitative RT-PCR on paired G 0 -quiescence and cycling LT-HSC and IT-HSC populations from 7 independent mouse sorts ( Figure 5E ). These results confirmed the microarray findings and in particular showed that Ap2a2 mRNA expression was, respectively, 4.5-and 7.5-fold increased in the LT-HSCs and IT-HSCs during quiescence compared with the cycling state.
Disparate Ap2a2 and Numb localization in HSC
In our screen, Ap2a2 was chosen as a candidate based on its association with the cell-fate determinant Numb. AP2A2 is the large ␣ adaptin subunit of the adaptor-protein 2 (AP-2) heterotetrameric complex that is integral to clathrin-coated pits during endocytosis of transmembrane receptors. 29, 30 AP2A2 has been shown to bind NUMB in mammalian cells, 31, 32 and in the Drosophila sensory organ precursor system, it is hypothesized that AP2A2 binding to NUMB allows the latter to be transported to the cell membrane for Notch receptor inhibition. 32 Within these contexts, we investigated the relationship between AP2A2 and NUMB localization in purified hematopoietic cells.
Initially, we analyzed adult CD150 ϩ 48 Ϫ LSK cells for endogenous localization of both proteins. Both AP2A2 and NUMB were localized in distinct vesicles ( Figure 6A ), but, surprisingly, the majority of these respective vesicles were not colocalized ( Figure  6A -B blue bars). Especially for AP2A2, individual vesicles appeared to coalesce as cytoplasmic clusters ( Figure 6C ). These AP2A2 and NUMB clusters more frequently colocalized ( Figure  6B -C red bars). Whereas AP2A2 in adult HSCs was more often localized asymmetrically in cytoplasmic clusters, in E14.5 FL CD150 ϩ 48 Ϫ Sca ϩ Mac1 ϩ Lin Ϫ cells, AP2A2 and NUMB were more often distributed symmetrically at the cortical membrane ( Figure  6D-E) . In a smaller fraction of E14.5 FL cells, AP2A2 was Means Ϯ SEM from 300 cell differential counts with respective GFP ϩ -transduced cells from independent experiments for vector (n ϭ 5), pAp2a2 (n ϭ 5), and NA10HD (n ϭ 2). Statistical significance between vector and Ap2a2 was P ϭ .002 and for NA10HD, *P Յ .0001). (E) Quantitative RT-PCR expressed as G0:cycling ratio (mean Ϯ SEM) from LT-HSC (CD49b Ϫ Rho low LSK) and IT-HSC (CD49b ϩ Rho low LSK) populations paired for G0-quiescent and cycling from 7 independent sorts. Both Ccnb1 (Cyclin B1) as part of the cell-cycle network 6 and Gpsm2, which is involved in active mitotic spindle orientation, [8] [9] [10] serve as effective internal controls given their (expected) relative higher expression during cycling (see also supplemental Figure 2C ). localized asymmetrically, and often when NUMB remained symmetrically distributed ( Figure 6F ). In both E14.5 FL CD150 ϩ 48 Ϫ Sca ϩ Mac1 ϩ Lin Ϫ and adult CD150 ϩ 48 Ϫ LSK cells during mitoses, the asynchronous distribution of Ap2a2 and Numb vesicles persisted (Figure 6G-H) .
Recent studies 18, 33, 34 have suggested that an underlying mechanism of mammalian cancer cell expansion includes disruption of the balance between symmetric cell division (SCD) and ACD. We analyzed the distribution of AP2A2 and NUMB in 2 murine myeloid leukemia lines derived in our laboratory (FLA2 and FLB1; Figure 6I ). In both lines, the symmetric distribution patterns resembled that found in E14.5 FL CD150 ϩ 48 Ϫ Sca ϩ Mac1 ϩ Lin Ϫ cells (compare Figure 6E with I) . This may infer that leukemia cells and primitive hematopoietic cells during development are balanced toward SCD pathways that theoretically drive their expansion. Interestingly, when we transduced adult CD150 ϩ 48 Ϫ LSK cells with the expansion factors HoxB4 or NA10HD, the AP2A2 distribution was altered from a predominantly asymmetric to symmetric pattern ( Figure 6J -K and supplemental Figure 2D ). This change in Ap2a2 protein distribution induced by HoxB4 is in contrast to the absence of change at the mRNA level ( Figure 1D) , and suggests that a relocalization of fate determinant(s) may contribute to HoxB4-and NA10HD-induced HSC expansion.
Ap2a2 segregation during HSC mitosis
Another important aspect of our investigations was to identify potential cell-fate determinants that would clearly delineate an ACD, with the eventual aim of prospective isolation of daughter cells for further single progeny cell studies. Specifically for this purpose, we generated 28 candidates (Figure 2A and http:// www.bioinfo.iric.ca/self-renewal/) fused in-frame with fluorescence proteins for live-cell videomicroscopy. In investigating ACD, the overexpression of a polarity factor with possible loss of polarity could theoretically skew mitoses toward SCD and thereby mask potential ACD mitoses. However, conversely and importantly, within this context, any candidate actually seen to asymmetrically segregate at division could be argued to be using stable intrinsic pathway(s) for ACD.
Based on this screen and on our complementary shRNA screen, 35 we initially video-screened Ap2a2, Numb, and Par6␣ cherry fusions. Of these candidates, only AP2A2 has shown clear asymmetric segregation at mitosis in purified HSCs, suggesting a possible specificity for Ap2a2 in ACD. During an ACD, cytoplasmic AP2A2 vesicles cluster asymmetrically during interphase and throughout mitosis before preferential segregation into only one daughter cell at division ( Figure 7A These distinct and replicable differences in AP2A2 localization during mitoses allowed us to quantify hematopoietic cell division as either an ACD or SCD ( Figure 7E It has also been reported recently that external niche factors are able to influence the balance between ACD and SCD in hematopoietic precursors. 18 With respect to the localization of AP2A2, we have confirmed this phenomenon. In contrast to when HSCs were cultured with a NIH 3T3 layer (ie, GPϩE-86 cells) as per Figure 7E 
Discussion
Clear supporting evidence for the presumption of ACD governing self-renewal in the hematopoietic system has been lacking. In addressing this question in the present study, we have acquired materials that have-and will continue to be-an important resource for our future studies in this field. In an established gain-of-function screen, we have identified the endocytic gene Ap2a2 as a novel in vivo agonist of mouse LT-HSC activity. When overexpressed in populations enriched for LT-HSCs, AP2A2 clearly segregates asymmetrically during mitosis in a significant proportion of these cells. Within these contexts, we conclude that ACD is operational in primitive hematopoietic cells enriched for LT-HSCs.
The finding of Ap2a2-transduced HSCs maintaining enhanced HSC activity after both in vitro cultured and secondary in vivo transplantation in the relative absence of increased HSC numbers suggests that these transduced HSCs are either favored or maintained for ACD as opposed to SCD. One possibility, given the heterogeneity within even the small population of LT-HSCs, may be that the subset of dormant LT-HSCs is intrinsically restricted to ACD, thereby ensuring that one daughter HSC retains the dormant state whereas the nondormant daughter HSC undergoes expansion SCDs. Therefore, whereas Ap2a2-transduced LT-HSCs are maintained in quiescence in vitro, on in vivo transplantation, these Ap2a2-transduced dormant HSCs have a potent proliferative output. This phenomenon of clonal variability in proliferative and Figure 6E and I and C and F, respectively. D3-5 and D7-12 refer to days after CD150 ϩ 48 Ϫ KLS cell transduction with Ap2a2. NIH 3T3 (ie, GPϩE-86) and OP9 are respective feeder layers. CK refers to cytokinesis seen (ie, a successful mitotic division). Failed M (mitosis)-apoptosis was defined as cells seen to be in mitosis for longer than 4 hours, because these cells would eventually abort mitosis to reenter interphase or undergo apoptosis. Analyses based on accumulated total number of dividing cells seen in each time period. (E) D3-5 with NIH 3T3 layer, total cells ϭ 162 from 3 independent experiments; D7-12 with NIH 3T3 layer, total cells ϭ 128 from 2 independent experiments. (F) D3-5 with OP9 layer, total cells ϭ 147 from 2 independent experiments. All values presented are means Ϯ SEM of respective experiment groups.
self-renewal capabilities within HSC populations has been reported previously. 37 Interestingly, the dormant fraction was seen to be 20%-30% of the total LT-HSC population, 26 which is similar to the percentage of ACDs seen in our in vitro videomicroscopy of Ap2a2-transduced HSCs. Our hypothesis of LT-HSC dormancy restricted to ACD is currently being addressed through postmitotic single-cell analyses.
In a parallel study to also identify novel HSC regulators, we performed and published an RNAi screen on a large cohort of our candidate polarity genes, 35 which included 3 shRNAs to Ap2a2. In the context of the current overexpression screen showing enhanced activity of Ap2a2-transduced HSCs, one might have expected impaired HSC repopulation with shRNA to Ap2a2. To try to understand why this was not the case for the 3 shRNAs to Ap2a2 in our RNAi screen (http://www.bioinfo.iric.ca.self-renewal/), the initial caveat was that confirmation of specific gene knockdown was only performed retrospectively with the hairpins that provided impaired or enhanced HSC repopulation at the primary screen level. After screening, quantitative RT-PCR to assess Ap2a2 mRNA levels with the 1-, 2-, and 3-shAp2a2 hairpins showed that the maximal Ap2a2 knockdown was only 50% with 3-shAp2a2. Although the use of 4-and 5-shRNAs to Ap2a2 with greater knockdown also did not definitively show impairment of HSC reconstitution (supplemental Figure 2A-B) , this has to be taken within the confines of our assay. For example, the RNAi screen identified Prkcz (also known as atypical protein kinase C [aPKC]) as an enhancer of HSC activity, yet recent conditional aPKC studies demonstrated its dispensability in hematopoiesis. 47 Given that AP2A2 is part of the AP-2 heterotetrameric endocytic complex, with potential for redundancy from partners in the same complex, it might also require a conditional Ap2a2 knock-out to see a hematopoiesis-specific phenotype.
In the setting of the crucial role of Ap2a2 in AP-2 clathrin-mediated endocytosis of transmembrane receptors, its overexpression in HSCs may either enhance or suppress the membrane expression of hematopoietic cytokine receptors known to be internalized via this endocytic pathway. 38 For example, thrombopoietin signaling is an important mediator of HSC quiescence, 39, 40 and the thrombopoietin receptor is internalized via AP-2 endocytosis. 38 Because receptor internalization into endosomes form platform hubs of signaling, 41, 42 Ap2a2-endosomes could involve the intersection of multiple signaling pathways such as tyrosine kinases and TGF␤-and G-coupled protein receptors. The in vitro effect of Ap2a2 overexpression on the HSCs could then result in either a niche-sensitized or niche-resistant HSCs that, after in vivo transplantation with subsequent asymmetric Ap2a2 segregation, would mediate differential composition or trafficking of signaling endosomes. In either case, Ap2a2-transduced HSCs seem to maintain a proliferative advantage.
Alternatively, theAp2a2 endocytosis link may also function independently from cell signaling, because other essential cellular functions that can determine cell fate, such as cell cycle, apoptosis, and RNAi regulation, have been documented within the endocytic trafficking network. 41, 43 The ability provided by observing asymmetric Ap2a2 segregation during HSC division delivers a unique opportunity to further investigate some of these aforementioned mechanisms.
Instinctively, the Ap2a2-Numb interaction would seem to be a key mechanism by which Ap2a2 might influence HSC activity given the role of Numb as an inhibitor of Notch signaling. However, the disparity in localization of AP2A2 and NUMB is suggestive of differing and distinct mechanistic pathways for these 2 proteins in hematopoietic cell-fate decisions. In support of this is the absence of HSC phenotypes in the Numb-Numblike conditional mutant mouse 44 and in Notch-signaling mutant mice. 45, 46 Whether this phenomenon of AP2A2 and NUMB disparity is specific to primitive hematopoietic cells or if it occurs in other regenerative mammalian tissues remains to be explored. In addition, aPKC and aPKC, mammalian homologs of another classic invertebrate cell-fate determinant, aPKC, have been found to be dispensable for mammalian HSC activity, 47 supporting the idea that ACD in mammalian HSC self-renewal may involve as-yet-unidentified cell-fate determinants.
An important potential perspective relates to cancer, for which, apart from the possibility of tumors corrupting endosome signaling pathways for unrestrained growth, 48 there is significant accumulation of data from the Drosophila system linking perturbation of polarity and ACD at the stem-cell level to abnormal cell proliferation and cancer. 33, 49 Moreover, there is a growing list of regulators of endocytosis that are aberrantly expressed in both human solid tissue and subtypes of hematologic cancers. 48 Two studies have reported that the balance between asymmetric versus symmetric divisions can be altered by, respectively, an oncogene (NUP98-HoxA9) in mammalian HSCs 18 and by a tumor suppressor (p53) in breast cancer stem cells, 34 with the implication that an underlying mechanism of both blood and solid-tissue cancers may be a perturbation of ACD. The fact that our mouse leukemias exhibited a symmetric pattern of Ap2a2 distribution potentially adds to these observations, and corruption of cell-fate mechanisms by cancer stem cells may become a critical tool used to fight oncogenesis.
